Rising Syphilis Rates and Sexual Health Service Challenges

Elizabeth Holmes has been found guilty of fraud. We ask what lessons her downfall holds for Theranos’s high-profile backers—and for a startup culture of hype before science. As Apple crosses a $3trn valuation we examine the motives for its stop-start forays into the competitive streaming-video business. And what lies behind the curious resurgence of syphilis.

For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer